Screener
CytomX Therapeutics CTMX Balance Sheet Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $17.22M-64.9% | $28.83M-39.4% | $12.67M-66.7% | $34.19M-15.8% | $49.04M+13.4% | ||
| $313.06M+187% | $317.88M+885% | $124.39M+98.8% | $109.44M+42.1% | $109.05M+16.1% | ||
| $37.49M+1,906% | $646K-67.0% | $2.01M-35.1% | $1.63M-51.4% | $1.87M-32.6% | ||
| $373.16M+127% | $353.1M+308% | $143.92M+34.1% | $149.22M+20.2% | $164.62M+15.1% | ||
| $1.08M-44.6% | $1.09M-51.1% | $1.3M-47.1% | $1.72M-41.5% | $1.95M-41.3% | ||
| $949K0.0% | $949K0.0% | $949K0.0% | $949K0.0% | $949K0.0% | ||
| $365K-28.4% | $401K-26.7% | $438K-24.9% | $474K-23.5% | $510K-22.3% | ||
| $381.23M+118% | $359.36M+265% | $151.57M+25.7% | $158.25M+13.9% | $175.06M+9.9% | ||
| $1.94M+754% | $1.37M+396% | $1.3M+19.6% | $646K-54.6% | $227K-62.8% | ||
| $24.07M+9.2% | $17.88M-46.2% | $26.88M-60.0% | $22.38M-76.7% | $22.05M-82.2% | ||
| $39.86M+1.6% | $34.02M-32.2% | $46.62M-45.7% | $41.03M-65.6% | $39.22M-72.5% | ||
| $79.16M+43.5% | $39.41M-46.3% | $52.56M-56.6% | $50.87M-68.7% | $55.15M-71.0% | ||
| $2K0.0% | $2K+100% | $2K+100% | $2K+100% | $2K+100% | ||
| -$750.86M-12.4% | -$730.2M-9.3% | -$711.95M-2.9% | -$682.44M+3.9% | -$668.21M+6.7% | ||
| $302.07M+152% | $319.94M+1,177% | $99.01M+21,812% | $107.39M+558% | $119.91M+484% | ||
| $381.23M+118% | $359.36M+265% | $151.57M+25.7% | $158.25M+13.9% | $175.06M+9.9% |
FAQ
- What are CytomX Therapeutics's total assets?
- CytomX Therapeutics (CTMX) holds $381.2M in total assets, up 117.8% year over year.
- How much debt does CytomX Therapeutics have?
- CytomX Therapeutics carries $5.7M in total debt against $302.1M of shareholders' equity, a debt-to-equity ratio of 0.02.
- How much cash does CytomX Therapeutics have?
- CytomX Therapeutics holds $17.2M in cash and equivalents.
- Can CytomX Therapeutics cover its short-term obligations?
- Its current ratio is 9.36 — current assets exceed current liabilities.
- Where does CytomX Therapeutics's balance sheet data come from?
- Every line is extracted from CytomX Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
